AstraZeneca PLC
AZN · NASDAQ
9/30/2025 | 6/30/2025 | 3/30/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $239,916 | $216,628 | $227,850 | $203,112 |
| - Cash | $8,143 | $7,058 | $5,230 | $5,488 |
| + Debt | $32,661 | $32,839 | $31,717 | $30,114 |
| Enterprise Value | $264,434 | $242,409 | $254,337 | $227,738 |
| Revenue | $15,191 | $14,457 | $13,588 | $14,891 |
| % Growth | 5.1% | 6.4% | -8.8% | – |
| Gross Profit | $12,329 | $11,984 | $11,347 | $12,166 |
| % Margin | 81.2% | 82.9% | 83.5% | 81.7% |
| EBITDA | $5,142 | $4,955 | $5,035 | $2,809 |
| % Margin | 33.8% | 34.3% | 37.1% | 18.9% |
| Net Income | $2,533 | $2,450 | $2,916 | $1,500 |
| % Margin | 16.7% | 16.9% | 21.5% | 10.1% |
| EPS Diluted | 0.81 | 0.79 | 0.94 | 0.48 |
| % Growth | 2.5% | -16% | 95.8% | – |
| Operating Cash Flow | $5,134 | $3,386 | $3,713 | $2,907 |
| Capital Expenditures | -$686 | -$1,923 | -$429 | -$955 |
| Free Cash Flow | $4,448 | $1,463 | $3,284 | $1,952 |